Expression of erythropoietin and its receptor in human renal cell carcinoma

Tumor Biology

Volumn 30, Issue 2, 2009, Pages 86-92

  Papworth, Karin ^a   Bergh, Anders ^a   Grankvist, Kjell ^a   Ljungberg, Börje ^a   Rasmuson, Torgny ^a  

^a UMEÅ UNIVERSITY   (Sweden)

Author keywords

Erythropoietin; Erythropoietin receptor; Haemoglobin; Immunohistochemistry; Prognosis; Renal cell carcinoma; Tissue microarray

Indexed keywords

ERYTHROPOIETIN; ERYTHROPOIETIN RECEPTOR; HEMOGLOBIN; TUMOR MARKER;

AGED; ARTICLE; CANCER GRADING; CANCER STAGING; CANCER SURVIVAL; CANCER TISSUE; CONTROLLED STUDY; FEMALE; HEMOGLOBIN BLOOD LEVEL; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KIDNEY CARCINOMA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; TISSUE MICROARRAY; BLOOD; GENE EXPRESSION; GENETICS; METABOLISM; MIDDLE AGED; PATHOLOGY;

AGED; CARCINOMA, RENAL CELL; ERYTHROPOIETIN; FEMALE; GENE EXPRESSION; HEMOGLOBINS; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; RECEPTORS, ERYTHROPOIETIN; TISSUE ARRAY ANALYSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 65449187188     PISSN: 10104283     EISSN: None     Source Type: Journal    
DOI: 10.1159/000216844     Document Type: Article

References (25)

1. Dagnon K, Pacary E, Commo F, Antoine M, Bernaudin M, Bernaudin JF, Callard P: Expression of erythropoietin and erythropoietin receptor in non-small cell lung carcinomas. Clin Cancer Res 2005; 11:993-999.
2. Hardee ME, Arcasoy MO, Blackwell KL, Kirkpatrick JP, Dewhirst MW: Erythropoi-etin biology in cancer. Clin Cancer Res 2006; 12: 332-339.
3. Lai SY, Grandis JR: Understanding the presence and function of erythropoietin receptors on cancer cells. J Clin Oncol 2006; 24: 4675-4676.
4. Kazal LA, Erslev AJ: Erythropoietin production in renal tumors. Ann Clin Sci 1975; 5: 98-109.
5. Murphy GP, Kenny GM, Mirand EA: Eryth-ropoietin levels in patients with renal tumors or cysts. Cancer 1970; 26: 191-194.
6. Sherwood JB, Goldwasser E: Erythropoietin production by human renal carcinoma cells in culture. Endocrinology 1976; 99:504-510.
7. Da Silva JL, Lacombe C, Bruneval P, Casade-vall N, Leporrier M, Camilleri JP, Bariety J, Tambourin P, Varet B: Tumor cells are the site of erythropoietin synthesis in human renal cancers associated with polycythemia. Blood 1990; 75:577-582.
8. Clark D, Kersting R, Rojiani AM: Erythro-poietin immunolocalization in renal cell carcinoma. Mod Pat hol 1998; 11: 24-28.
9. Noguchi Y, Goto T, Yufu Y, Uike N, Hasega-wa Y, Fukuda T, Jimi A, Funakoshi A: Gene expression of erythropoietin in renal cell carcinoma. Intern Med 1999; 38:991-994.
10. Sakamoto S, Igarashi T, Osumi N, Imamoto T, Tobe T, Kamiya M, Ito H: Erythropoietin-producing renal cell carcinoma in chronic hemodialysis patients: a report of two cases. Int J Urol 2003; 10:49-51.
11. Westenfelder C, Baranowski RL: Erythro-poietin stimulates proliferation of human renal carcinoma cells. Kidney Int 2000; 58: 647-657.
12. Lee YS, Vortmeyer AO, Lubensky IA, Vogel TW, Ikejiri B, Ferlicot S, Benoit G, Giraud S, Oldfield EH, Linehan WM, The BT, Richard S, Zhuang Z: Coexpression of erythropoietin and erythropoietin receptor in von Hippel-Lindau disease-associated renal cysts and renal cell carcinoma. Clin Cancer Res 2005; 11: 1059-1064.
13. Wiesener MS, Münchenhagen P, Gläser M, Sobottka BA, Kanup KX, Jozefowski K, Jür-gensen JS, Roigas J, Warnecke C, Gröne HJ, Maxwell PH, Willam C, Eckardt KU: Eryth-ropoietin gene expression in renal carcinoma is considerably more frequent than para-neoplastic polycythemia. Int J Cancer 2007; 121: 2434-2442.
14. Ljungberg B, Rasmuson T, Grankvist K: Erythropoietin in renal cell carcinoma: evaluation of its usefulness as a tumor marker. Eur Urol 1992; 21:160-163.
15. Michael A, Politi E, Havranek E, Corbishley C, Karapanagiotou L, Anderson C, Relph K, Syrigos KN, Pandha H: Prognostic significance of erythropoietin expression in human renal cell carcinoma. BJU Int 2007;100: 291-294.
16. Sobin L, Wittekind CH (eds): International Union Against Cancer (UICC) TNM Classification of Malignant Tumours, ed 6. Geneva, International Union Against Cancer, 2002.
17. Fuhrman SA, Lasky LC, Limas C: Prognostic significance of morphologic parameters in renal cell carcinoma. Am J Surg Pathol 1982; 6:655-563.
18. Kovacs G, Akhtar M, Beckwith BJ, Bugert P, Cooper CS, Delahunt B, Eble JN, Fleming S, Ljungberg B, Medeiros LJ, Moch H, Reuter VE, Ritz E, Roos G, Schmidt D, Srigley JR, Störkel S, van den Berg E, Zbar B: The Heidelberg classification of renal cell tumours. J Pathol 1997; 183:131-133.
19. Semenza GL: Regulation of erythropoietin production: new insights into molecular mechanisms of oxygen homeostasis. Hematol Oncol Clin North Am 1994; 8:863-884.
20. Banks RE, Tirukonda P, Taylor C, Hornigold N, Astuti D, Cohen D, Maher ER, Stanley AJ, Harnden P, Joyce A, Knowles M, Selby PJ: Genetic and epigenetic analysis of von Hippel-Lindau (VHL) gene alterations and relationship with clinical variables in sporadic renal cancer. Cancer Res 2006; 66:2000-2011.
21. Gross AJ, Wolff M, Fandrey J, Miersch WD, Dieckmann KP, Jelkman W: Prevalence of paraneoplastic erythropoietin production by renal cell carcinomas. Clin Investig 1994; 72: 337-340.
22. Magera JS, Leibovich BC, Lohse CM, Sen-gupta S, Cheville JC, Kwon ED, Blute ML: Association of abnormal preoperative laboratory values with survival after radical nephrectomy for clinically confined clear cell renal cell carcinoma. Urology 2008; 71: 278-282.
23. Lidgren A, Hedberg Y, Grankvist K, Ras-muson T, Bergh A, Ljungberg B: Hypoxia-inducible factor 1α expression in renal cell carcinoma analyzed by tissue microarray. Eur Urol 2006; 50: 1272-1277.
24. Saintigny P, Besse B, Callard P, Vergnaud AC, Czernichow S, Colombat M, Girard P, Validire P, Breau JL, Bernaudin JF, Soria JC: Erythropoietin and erythropoietin receptor coexpression is associated with poor survival in stage I non-small cell lung cancer. Clin Cancer Res 2007; 13:4825-4831.
25. Elliott S, Busse L, Bass MB, Lu H, Sarosi I, Sinclair AM, Spahr C, Um M, Van G, Begley CG: Anti-Epo receptor antibodies do not predict Epo receptor expression. Blood 2006; 107: 1892-1895.